Valneva SE (VALN) Current Deferred Revenue (2021 - 2025)

Valneva SE's (VALN) quarterly Current Deferred Revenue came in at $502866.8 in Q4 2025, down 84.37% year-on-year from $3.2 million in Q4 2024, and down 98.82% quarter-over-quarter from $42.5 million in Q2 2025.

Valneva SE (VALN) Current Deferred Revenue (2021 - 2025) Analysis & Trends

Valneva SE has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $502866.8 for Q4 2025.

  • Current Deferred Revenue for Q4 2025 came in at $502866.8, down 84.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $502866.8 (down 84.37% YoY), and the FY2025 annual result was $502866.8, down 84.37% from the prior year.
  • Current Deferred Revenue came in at $502866.8 for Q4 2025 at Valneva SE, down from $42.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $141.9 million in Q4 2021 to a low of $502866.8 in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $9.6 million (2022), against an average of $32.0 million.
  • Across the five-year window, Current Deferred Revenue slumped 93.23% in 2022 and jumped 108.89% in 2025, its largest moves.
  • Valneva SE's Current Deferred Revenue stood at $141.9 million in 2021, then plunged by 93.23% to $9.6 million in 2022, then sank by 36.16% to $6.1 million in 2023, then slumped by 47.53% to $3.2 million in 2024, then tumbled by 84.37% to $502866.8 in 2025.
  • The last three Current Deferred Revenue figures came in at $502866.8 (Q4 2025), $42.5 million (Q2 2025), and $3.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 502,866.80
Jun 30, 2025 42.51 Mn
Dec 31, 2024 3.22 Mn
Jun 30, 2024 20.35 Mn
Dec 31, 2023 6.13 Mn
Dec 31, 2022 9.60 Mn
Dec 31, 2021 141.87 Mn